XIAP protects oligodendrocytes against cell death in vitro but has no functional role in toxic demyelination

GLIA

Volumn 60, Issue 2, 2012, Pages 271-280

  Rena Hesse, Amke ^a   Hagemeier, Karin ^a   Lürbke, Alexander ^a   Held, Jasmin ^b   Friedman, Hana ^c   Peterson, Alan ^c   Brück, Wolfgang ^b   Kuhlmann, Tanja ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Cuprizone; Oligodendrocytes; XIAP

Indexed keywords

X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; DEMYELINATION; FEMALE; MALE; NERVE CELL NECROSIS; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELL LINE; CHELATING AGENTS; CUPRIZONE; CYTOPROTECTION; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE FIBERS, MYELINATED; NEURAL PATHWAYS; OLIGODENDROGLIA; PRIMARY CELL CULTURE; RATS; UP-REGULATION; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 83055176361     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.21261     Document Type: Article

References (53)

1. Back SA, Han BH, Luo NL, Chricton CA, Xanthoudakis S, Tam J, Arvin KL, Holtzman DM. 2002. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci 22: 455-463.
2. Blakemore WF. 1972. Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice. J Neurocytol 1: 413-426.
3. Bonetti B, Raine CS. 1997. Multiple sclerosis: Oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann Neurol 42: 74-84.
4. Brück W, Herms J, Brockmann K, Schulz-Schaeffer W, Hanefeld F. 2001. Myelinopathia centralis diffusa (vanishing white matter disease): Evidence of apoptotic oligodendrocyte degeneration in early lesion development. Ann Neurol 50: 532-536.
5. Bruck W, Kuhlmann T, Stadelmann C. 2003. Remyelination in multiple sclerosis. J Neurol Sci 206: 181-185.
6. Cheung HH, Plenchette S, Kern CJ, Mahoney DJ, Korneluk RG. 2008. The RING domain of cIAP1 mediates the degradation of RING-bearing inhibitor of apoptosis proteins by distinct pathways. Mol Biol Cell 19: 2729-2740.
7. Crocker SJ, Liston P, Anisman H, Lee CJ, Smith PD, Earl N, Thompson CS, Park DS, Korneluk RG, Robertson GS. 2003. Attenuation of MPTP-induced neurotoxicity and behavioural impairment in NSE-XIAP transgenic mice. Neurobiol Dis 12: 150-161.
8. D'Souza SD, Bonetti B, Balasingam V, Cashman NR, Barker PA, Troutt AB, Raine CS, Antel JP. 1996. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med 184: 2361-2370.
9. Dai Y, Rahmani M, Grant S. 2003. Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-kappaB-dependent process. Oncogene 22: 7108-7122.
10. Duckett CS, Li F, Wang Y, Tomaselli KJ, Thompson CB, Armstrong RC. 1998. Human IAP-like protein regulates programmed cell death downstream of Bcl-xL and cytochrome c. Mol Cell Biol 18: 608-615.
11. Eberhardt O, Coelln RV, Kugler S, Lindenau J, Rathke-Hartlieb S, Gerhardt E, Haid S, Isenmann S, Gravel C, Srinivasan A, Bahr M, Weller M, Dichgans J, Schulz JB. 2000. Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson's disease. J Neurosci 20: 9126-9134.
12. Eckelman BP, Salvesen GS, Scott FL. 2006. Human inhibitor of apoptosis proteins: Why XIAP is the black sheep of the family. EMBO Rep 7: 988-994.
13. Galban S, Duckett CS. 2010. XIAP as a ubiquitin ligase in cellular signaling. Cell Death Differ 17: 54-60.
14. Harlin H, Reffey SB, Duckett CS, Lindsten T, Thompson CB. 2001. Characterization of XIAP-deficient mice. Mol Cell Biol 21: 3604-3608.
15. Hesse A, Wagner M, Held J, Bruck W, Salinas-Riester G, Hao Z, Waisman A, Kuhlmann T. 2010. In toxic demyelination oligodendroglial cell death occurs early and is FAS independent. Neurobiol Dis 37: 362-369.
16. Holcik M, Yeh C, Korneluk RG, Chow T. 2000. Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death. Oncogene 19: 4174-4177.
17. Hunter AM, LaCasse EC, Korneluk RG. 2007. The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 12: 1543-1568.
18. Jin HS, Lee DH, Kim DH, Chung JH, Lee SJ, Lee TH. 2009. cIAP1, cIAP2, and XIAP act cooperatively via nonredundant pathways to regulate genotoxic stress-induced nuclear factor-kappaB activation. Cancer Res 69: 1782-1791.
19. Jin Y, McEwen ML, Ghandour MS, Springer JE. 2004. Overexpression of XIAP inhibits apoptotic cell death in an oligodendroglial cell line. Cell Mol Neurobiol 24: 853-863.
20. Kaur S, Wang F, Venkatraman M, Arsura M. 2005. X-linked inhibitor of apoptosis (XIAP) inhibits c-Jun N-terminal kinase 1 (JNK1) activation by transforming growth factor beta1 (TGF-beta1) through ubiquitin-mediated proteosomal degradation of the TGF-beta1-activated kinase 1 (TAK1). J Biol Chem 280: 38599-38608.
21. Korhonen L, Belluardo N, Lindholm D. 2001. Regulation of X-chromosome-linked inhibitor of apoptosis protein in kainic acid-induced neuronal death in the rat hippocampus. Mol Cell Neurosci 17: 364-372.
22. Kügler S, Straten G, Kreppel F, Isenmann S, Liston P, Bähr M. 2000. The X-linked inhibitor of apoptosis (XIAP) prevents cell death in axotomized CNS neurons in vivo. Cell Death Differ 7: 815-824.
23. Kuhlmann T, Lucchinetti C, Zettl UK, Bitsch A, Lassmann H, Brück W. 1999. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions. Glia 28: 34-39.
24. Levkau B, Garton KJ, Ferri N, Kloke K, Nofer JR, Baba HA, Raines EW, Breithardt G. 2001. xIAP induces cell-cycle arrest and activates nuclear factor-kappaB: New survival pathways disabled by caspase-mediated cleavage during apoptosis of human endothelial cells. Circ Res 88: 282-290.
25. Liou JY, Matijevic-Aleksic N, Lee S, Wu KK. 2007. Prostacyclin inhibits endothelial cell XIAP ubiquitination and degradation. J Cell Physiol 212: 840-848.
26. Liu WH, Hsiao HW, Tsou WI, Lai MZ. 2007. Notch inhibits apoptosis by direct interference with XIAP ubiquitination and degradation. EMBO J 26: 1660-1669.
27. Lotocki G, Alonso OF, Frydel B, Dietrich WD, Keane RW. 2003. Monoubiquitination and cellular distribution of XIAP in neurons after traumatic brain injury. J Cereb Blood Flow Metab 23: 1129-1136.
28. Louis JC, Magal E, Muir D, Manthorpe M, Varon S. 1992. CG-4, a new bipotential glial cell line from rat brain, is capable of differentiating in vitro into either mature oligodendrocytes or type-2 astrocytes. J Neurosci Res 31: 193-204.
29. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. 1999. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 122: 2279-2295.
30. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. 2000. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann Neurol 47: 707-717.
31. Matsushima GK, Morell P. 2001. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11: 107-116.
32. Moore CS, Hebb AL, Robertson GS. 2008. Inhibitor of apoptosis protein (IAP) profiling in experimental autoimmune encephalomyelitis (EAE) implicates increased XIAP in T lymphocytes. J Neuroimmunol 193: 94-105.
33. Parton M, Krajewski S, Smith I, Krajewska M, Archer C, Naito M, Ahern R, Reed J, Dowsett M. 2002. Coordinate expression of apoptosis-associated proteins in human breast cancer before and during chemotherapy. Clin Cancer Res 8: 2100-2108.
34. Richter-Landsberg C, Heinrich M. 1996. OLN-93: A new permanent oligodendroglia cell line derived from primary rat brain glial cultures. J Neurosci Res 45: 161-173.
35. Rumble JM, Bertrand MJ, Csomos RA, Wright CW, Albert L, Mak TW, Barker PA, Duckett CS. 2008. Apoptotic sensitivity of murine IAP-deficient cells. Biochem J 415: 21-25.
36. Sanna MG, da Silva CJ, Ducrey O, Lee J, Nomoto K, Schrantz N, Deveraux QL, Ulevitch RJ. 2002. IAP suppression of apoptosis involves distinct mechanisms: The TAK1/JNK1 signaling cascade and caspase inhibition. Mol Cell Biol 22: 1754-1766.
37. Schimmer AD, Dalili S, Batey RA, Riedl SJ. 2006. Targeting XIAP for the treatment of malignancy. Cell Death Differ 13: 179-188.
38. Shibata M, Hisahara S, Hara H, Yamawaki T, Fukuuchi Y, Yuan J, Okano H, Miura M. 2000. Caspases determine the vulnerability of oligodendrocytes in the ischemic brain. J Clin Invest 106: 643-653.
39. Sohn D, Totzke G, Essmann F, Schulze-Osthoff K, Levkau B, Janicke RU. 2006. The proteasome is required for rapid initiation of death receptor-induced apoptosis. Mol Cell Biol 26: 1967-1978.
40. Stehlik C, de MR, Kumabashiri I, Schmid JA, Binder BR, Lipp J. 1998. Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J Exp Med 188: 211-216.
41. Straszewski-Chavez SL, Abrahams VM, Funai EF, Mor G. 2004. X-linked inhibitor of apoptosis (XIAP) confers human trophoblast cell resistance to Fas-mediated apoptosis. Mol Hum Reprod 10: 33-41.
42. Trapp BD, Nave KA. 2008. Multiple sclerosis: An immune or neurodegenerative disorder? Annu Rev Neurosci 31: 247-269.
43. Trapp T, Korhonen L, Besselmann M, Martinez R, Mercer E, Lindholm D. 2003. Transgenic mice overexpressing XIAP in neurons show better outcome after transient cerebral ischemia. Mol Cell Neurosci 23: 302-313.
44. Tsang AH, Lee YI, Ko HS, Savitt JM, Pletnikova O, Troncoso JC, Dawson VL, Dawson TM, Chung KK. 2009. S-nitrosylation of XIAP compromises neuronal survival in Parkinson's disease. Proc Natl Acad Sci U S A 106: 4900-4905.
45. Tun C, Guo W, Nguyen H, Yun B, Libby RT, Morrison RS, Garden GA. 2007. Activation of the extrinsic caspase pathway in cultured cortical neurons requires p53-mediated down-regulation of the X-linked inhibitor of apoptosis protein to induce apoptosis. J Neurochem 102: 1206-1219.
46. Wagenknecht B, Hermisson M, Groscurth P, Liston P, Krammer PH, Weller M. 2000. Proteasome inhibitor-induced apoptosis of glioma cells involves the processing of multiple caspases and cytochrome c release. J Neurochem 75: 2288-2297.
47. Wang J, Menchenton T, Yin S, Yu Z, Bance M, Morris DP, Moore CS, Korneluk RG, Robertson GS. 2008. Over-expression of X-linked inhibitor of apoptosis protein slows presbycusis in C57BL/6J mice. Neurobiol Aging.
48. Watkins TA, Emery B, Mulinyawe S, Barres BA. 2008. Distinct stages of myelination regulated by gamma-secretase and astrocytes in a rapidly myelinating CNS coculture system. Neuron 60: 555-569.
49. West T, Stump M, Lodygensky G, Neil JJ, Deshmukh M, Holtzman DM. 2009. Lack of X-linked inhibitor of apoptosis protein leads to increased apoptosis and tissue loss following neonatal brain injury. ASN Neuro 1.
50. Wosik K, Antel J, Kuhlmann T, Bruck W, Massie B, Nalbantoglu J. 2003. Oligodendrocyte injury in multiple sclerosis: A role for p53. J Neurochem 85: 635-644.
51. Xu D, Bureau Y, McIntyre D, Nicolson D, Liston P, Zhu Y, Fong W, Crocker S, Korneluk R, Robertson G. 1999. Attenuation of iscemia-induced cellular and behavioral deficits by X chromosome-linked inhibitor of apoptosis protein overexpression in the rat hippocampus. J Neurosci 19: 5026-5033.
52. Yang Y, Fang S, Jensen JP, Weissman AM, Ashwell JD. 2000. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 288: 874-877.
53. Zehntner SP, Bourbonniere L, Moore CS, Morris SJ, Methot D, St JM, Lacasse E, Hebb AL, Robertson GS, Durkin J, Gillard JW, Owens T. 2007. X-linked inhibitor of apoptosis regulates T cell effector function. J Immunol 179: 7553-7560.